The 10th World Orphan Drug Congress, the meeting place for the rare disease community, will be held from 11 to 14 November in Barcelona with the collaboration of CataloniaBio & HealthTech. 

This year the agenda covers the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases. Among the speakers, we highlighted the presence of two Catalan companies: Marc Martinell, CEO of Minoryx Therapeutics, and Clara Campàs, partner of Asabys Partners.

The 2018 edition attracted more than 500 attendees (80% decision makers), 275 companies and 200 high-level speakers.

For: Government authorities, industry, start-ups, investors and patient advocacy groups.

Language: English

Registration fees:

• CataloniaBioHT members: 20% discount. Ask for your code discount at secretaria@cataloniabioht.org
• General: from €1,345 to €3,345

More information

Follow it on Twitter with the hashtag #WODC2019